Search all trials

Find therapies in clinical trials near you – page 21

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 968
countries: 28
conditions: 2 103

3 968 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Breast cancer+7

Not recruiting

Registered drugNo placebo

Study of Sacituzumab Govitecan compared to standard therapy in HER2-negative breast cancer patients with high risk of relapse after neoadjuvant treatment

Registered drugNo placebo

Austria

Participants:18–64 years · 65+ years
Substances:Capecitabine

Contact Research Centre

Cholangiocarcinoma

Not recruiting

Registered drugNo placebo

Study Comparing Pemigatinib and Gemcitabine Plus Cisplatin for First-Line Treatment in Patients with Unresectable or Metastatic Cholangiocarcinoma with FGFR2 Rearrangement

Registered drugNo placebo

Austria

Participants:18–64 years · 65+ years
Substances:Cisplatin

Contact Research Centre

Cutaneous lupus erythematosus

Not recruiting

Investigational

Study on Anifrolumab for Adults with Chronic or Subacute Cutaneous Lupus Erythematosus Unresponsive to Antimalarial Therapy

Investigational

Austria

Participants:18–64 years · 65+ years
Substances:Anifrolumab

Contact Research Centre

Crohn's disease

Not recruiting

Investigational

Study on the Effects of Etrasimod Arginine for Patients with Moderate to Severe Crohn's Disease

Investigational

Austria

Participants:18–64 years · 65+ years
Substances:Etrasimod Arginine

Contact Research Centre

Hormone receptor positive HER2 negative breast cancer

Not recruiting

Registered drugNo placebo

Study Comparing Trastuzumab Deruxtecan with Chemotherapy for Patients with HER2-Low, Hormone Receptor Positive Breast Cancer After Endocrine Therapy Progression

Registered drugNo placebo

Austria

Participants:18–64 years · 65+ years
Substances:Capecitabine

Contact Research Centre

Fallopian tube cancer+2

Not recruiting

Registered drugNo placebo

Study of Nemvaleukin Alfa and Pembrolizumab for Patients with Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer.

Registered drugNo placebo

Austria

Participants:18–64 years · 65+ years
Substances:Nemvaleukin Alfa

Contact Research Centre

Plasma cell myeloma

Not recruiting

Registered drugNo placebo

Study on Elranatamab and Daratumumab for Patients with Relapsed or Refractory Multiple Myeloma After Prior Treatment

Registered drugNo placebo

Austria

Participants:18–64 years · 65+ years
Substances:Daratumumab

Contact Research Centre

Non-small cell lung cancer

Not recruiting

Registered drugNo placebo

Study of Pembrolizumab and Lenvatinib for Patients with Resectable Non-Small-Cell Lung Cancer

Registered drugNo placebo

Austria

Participants:18–64 years · 65+ years
Substances:Lenvatinib

Contact Research Centre

Breast cancer

Not recruiting

Registered drug

Study of Camizestrant and CDK4/6 Inhibitor for Patients with Advanced Breast Cancer with ESR1 Mutation

Registered drug

Austria

Participants:18–64 years · 65+ years
Substances:Abemaciclib

Contact Research Centre

Granulomatosis with polyangiitis+1

Not recruiting

Investigational

Study of iptacopan effectiveness in achieving remission in patients with active ANCA-associated vasculitis

Investigational

Austria

Participants:18–64 years · 65+ years
Substances:Iptacopan

Contact Research Centre

Cardiac amyloidosis

Not recruiting

Investigational

Study on the Effectiveness and Safety of Eplontersen for Patients with Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM)

Investigational

Austria

Participants:18–64 years · 65+ years
Substances:Eplontersen

Contact Research Centre

Prostate cancer

Not recruiting

InvestigationalNo placebo

Study of Apalutamide for Patients with High-Risk Prostate Cancer After Prostate Removal

InvestigationalNo placebo

Austria

Participants:18–64 years · 65+ years
Substances:Apalutamide

Contact Research Centre

Find therapies in clinical trials near you – page 21

363 trials match your criteria

Breast cancer+7

Study of Sacituzumab Govitecan compared to standard therapy in HER2-negative breast cancer patients with high risk of relapse after neoadjuvant treatment

Cholangiocarcinoma

Study Comparing Pemigatinib and Gemcitabine Plus Cisplatin for First-Line Treatment in Patients with Unresectable or Metastatic Cholangiocarcinoma with FGFR2 Rearrangement

Cutaneous lupus erythematosus

Study on Anifrolumab for Adults with Chronic or Subacute Cutaneous Lupus Erythematosus Unresponsive to Antimalarial Therapy

Crohn's disease

Study on the Effects of Etrasimod Arginine for Patients with Moderate to Severe Crohn's Disease

Hormone receptor positive HER2 negative breast cancer

Study Comparing Trastuzumab Deruxtecan with Chemotherapy for Patients with HER2-Low, Hormone Receptor Positive Breast Cancer After Endocrine Therapy Progression

Fallopian tube cancer+2

Study of Nemvaleukin Alfa and Pembrolizumab for Patients with Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer.

Plasma cell myeloma

Study on Elranatamab and Daratumumab for Patients with Relapsed or Refractory Multiple Myeloma After Prior Treatment

Non-small cell lung cancer

Study of Pembrolizumab and Lenvatinib for Patients with Resectable Non-Small-Cell Lung Cancer

Breast cancer

Study of Camizestrant and CDK4/6 Inhibitor for Patients with Advanced Breast Cancer with ESR1 Mutation

Granulomatosis with polyangiitis+1

Study of iptacopan effectiveness in achieving remission in patients with active ANCA-associated vasculitis

Cardiac amyloidosis

Study on the Effectiveness and Safety of Eplontersen for Patients with Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM)

Prostate cancer

Study of Apalutamide for Patients with High-Risk Prostate Cancer After Prostate Removal

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.